Liver steatosis

Disease

9 papers9 findings

  • Animals9

Interventions

4

Nicotinamide riboside + magnesium-l-theanine

downin rats1

1 study
  1. Nicotinamide riboside + magnesium-l-theanine decreases liver steatosis in rats.

    “Histological analysis confirmed amelioration of CVS-induced liver steatosis and intestinal architectural damage.”

    Animalschronic variable stressliver40 days

    Combined nicotinamide riboside and magnesium-l-theanine protects against chronic stress-induced gut-liver injury by modulating NAD⁺ and metabolic pathways

    Molecular biology reports3 Oct 2025

More on Nicotinamide riboside + magnesium-l-theanine

Environmental enrichment

downin mice1

1 study
  1. Environmental enrichment decreases liver steatosis in mice.

    “EE decreased age-related liver steatosis”

    Animalsliver

    Implementation of environmental enrichment after middle age promotes healthy aging

    Aging20 Jul 2018

More on Environmental enrichment

SRT1720

downin mice1

1 study
  1. SRT1720 decreases liver steatosis in mice.

    “lifespan extension is accompanied by health benefits including reduced liver steatosis”

    Animalsin mice fed a high-fat diet

    SRT1720 improves survival and healthspan of obese mice

    Scientific reports18 Aug 2011

More on SRT1720

Resveratrol

downin mice1

1 study
  1. Resveratrol decreases liver steatosis in mice.

    “resveratrol reversed liver steatosis, lipid peroxidaton, and the defenestration phenotypes observed in such mice.”

    Animalsin Wrn mutant miceliver

    Resveratrol improves insulin resistance hyperglycemia and hepatosteatosis but not hypertriglyceridemia, inflammation, and life span in a mouse model for Werner syndrome

    The journals of gerontology. Series A, Biological sciences and medical sciences25 Oct 2010

More on Resveratrol

Upstream

4

FDXR

downin mice1

1 study
  1. FDXR protects against liver steatosis in mice.

    “and liver steatosis”

    Animalsshown by Fdxr+/- and Trp53+/- mice

    Ferredoxin reductase and p53 are necessary for lipid homeostasis and tumor suppression through the ABCA1-SREBP pathway

    Oncogene4 Feb 2022

More on FDXR

MAP3K8

downin mice1

1 study
  1. MAP3K8 protects against liver steatosis in mice.

    “male Tpl2-KD mice had higher bodyweight and an increased incidence of liver steatosis”

    Animalsloss of Tpl2 kinase activitylivermales

    Tpl2 kinase regulates inflammation but not tumorigenesis in mice

    Toxicology and applied pharmacology13 Mar 2021

More on MAP3K8

ITPR2

upin mice1

1 study
  1. ITPR2 increases liver steatosis in mice.

    “less liver steatosis and fibrosis”

    Animalsknockoutliver

    Calcium channel ITPR2 and mitochondria-ER contacts promote cellular senescence and aging

    Nature communications1 Feb 2021

More on ITPR2

RBM38

upin mice1

1 study
  1. RBM38 increases liver steatosis in mice.

    “loss-of-Rbm38 markedly decreased the percentage of liver steatosis in TAp63+/- mice”

    Animalsin TAp63+/- miceliver

    The Rbm38-p63 feedback loop is critical for tumor suppression and longevity

    Oncogene9 Mar 2018

More on RBM38

Associations

1

RBM38

upin mice1

1 study
  1. RBM38 raises the risk of liver steatosis in mice.

    “S193D KI mice have a shortened life span and are prone to spontaneous tumors, chronic inflammation, and liver steatosis”

    AnimalsS193D knock-in

    Fine-tuning p53 activity by modulating the interaction between eukaryotic translation initiation factor eIF4E and RNA-binding protein RBM38

    Genes & development4 Mar 2021

More on RBM38

Trial sponsors

Latest

Nov 2025: 1Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 2Jul 2026: 1Aug 2026: 3Sep 2026: 4Oct 2026: 012 in 12 months